Galactosylated chitosan triptolide nanoparticles for overcoming hepatocellular carcinoma: Enhanced therapeutic efficacy, low toxicity, and validated network regulatory mechanisms

Immunosuppressive, anti-inflammatory and anti-cancer properties of triptolide: A mini review.

Samira Ziaei, Reginald Halaby · PubMed · 2016 · 148 citations · Full text

Medicine, Immunology, Pharmacology +17

pH-Sensitive Nanoformulated Triptolide as a Targeted Therapeutic Strategy for Hepatocellular Carcinoma

Daishun Ling, Hongping Xia, Wooram Park et al. · ACS Nano · 2014 · 136 citations

Pharmacy, Oncology, Pharmacology +17

Comprehensive analysis of microRNA-regulated protein interaction network reveals the tumor suppressive role of microRNA-149 in human hepatocellular carcinoma via targeting AKT-mTOR pathway

Yanqiong Zhang, Xiaodong Guo, Lu Xiong et al. · Molecular Cancer · 2014 · 103 citations · Full text

Medicine, Molecular Biology, Oncology +17

MicroRNA‐101 suppresses SOX9‐dependent tumorigenicity and promotes favorable prognosis of human hepatocellular carcinoma

Yanqiong Zhang, Xiaodong Guo, Lu Xiong et al. · FEBS Letters · 2012 · 102 citations · Full text

Medicine, Molecular Biology, Oncology +17

Uncovering pharmacological mechanisms of Wu-tou decoction acting on rheumatoid arthritis through systems approaches: drug-target prediction, network analysis and experimental validation

Yanqiong Zhang, Ming Bai, Bo Zhang et al. · Scientific Reports · 2015 · 98 citations · Full text

Medicine, Pharmacology, Systems Biology +17